| | Editorial Foreword Ther Clin Risk Manag. 2008 February; 4(1): i–ii. Published online 2008 February. PMCID: PMC2503672 Reviews Review of photodynamic therapy in actinic keratosis and basal cell carcinoma Marica B Ericson, Ann-Marie Wennberg, and Olle Larkö PMCID: PMC2503644 Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy Mischel G Neill, Rohan Shahani, and Alexandre R Zlotta PMCID: PMC2503646 Critical appraisal of medical devices in the management of cerebrovascular disease Michael J Schneck PMCID: PMC2503654 Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review Jason W Bennett, James S Lewis, II, and Michael W Ellis PMCID: PMC2503664 Serotonin receptor modulators in the treatment of irritable bowel syndrome Mohammad Fayyaz and Jeffrey M Lackner PMCID: PMC2503665 Why does the world need another rotavirus vaccine? Richard L Ward, Monica M McNeal, and A Duncan Steele PMCID: PMC2503666 A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®) Vandana A Govan PMCID: PMC2503667 Anidulafungin in the treatment of invasive fungal infections Kathryn Sabol and Tawanda Gumbo PMCID: PMC2503668 Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015 Robert A Bok PMCID: PMC2503669 Advances in the use of topical imiquimod to treat dermatologic disorders Francesco Lacarrubba, Maria Rita Nasca, and Giuseppe Micali PMCID: PMC2503670 A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting Mark A Ware1, Paul Daeninck, and Vincent Maida PMCID: PMC2503671 Trabectedin and its potential in the treatment of soft tissue sarcoma Philippe A Cassier, Armelle Dufresne, Jean-Yves Blay, and Jérôme Fayette PMCID: PMC2503645 A review of solifenacin in the treatment of urinary incontinence Ramandeep Basra and Con Kelleher PMCID: PMC2503647 A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma Teru Hideshima, Noopur Raje, Paul G Richardson, and Kenneth C Anderson PMCID: PMC2503648 Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results Putao Cen, Eric D Tetzlaff, and Jaffer A Ajani PMCID: PMC2503649 Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris Efstratios Vakirlis, Athanasios Kastanis, and Demetrios Ioannides PMCID: PMC2503650 Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate Omar S Din and Penella J Woll PMCID: PMC2503651 Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™) Martin Henkes, Heiko van der Kuip, and Walter E Aulitzky PMCID: PMC2503652 Long-term safety of aromatase inhibitors in the treatment of breast cancer Jean-Marc A Nabholtz PMCID: PMC2503653 Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma Ranjit K Goudar PMCID: PMC2503655 A review of topotecan in combination chemotherapy for advanced cervical cancer Minoo Robati, David Holtz, and Charles J Dunton PMCID: PMC2503656 Therapeutical approach to plasma homocysteine and cardiovascular risk reduction Marcello Ciaccio, Giulia Bivona, and Chiara Bellia PMCID: PMC2503657 Management of laryngopharyngeal reflux with proton pump inhibitors Christina Reimer and Peter Bytzer PMCID: PMC2503658 A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI) Lala M Dunbar, Derek M Tang, and Robert M Manausa PMCID: PMC2503659 Cannabinoids in the management of difficult to treat pain Ethan B Russo PMCID: PMC2503660 Zoledronic acid in the management of metastatic bone disease Thomas J Polascik and Vladimir Mouraviev PMCID: PMC2503661 Original Research Factors affecting therapeutic compliance: A review from the patient’s perspective Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, and Shu Chuen Li PMCID: PMC2503662 Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial Hong-nü Chu and Mei-juan Shen PMCID: PMC2503663 |
